Suchergebnisse - "Bergot, Emmanuel"

PubPharm (129)

11

Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension

enthalten in: Circulation | 2023

von Guignabert, C. | Savale, L. | Boucly, A. | +18

12

Cytokines as prognostic biomarkers in pulmonary arterial hypertension

enthalten in: The European respiratory journal | 2023

von Boucly, A. | Tu, L. | Guignabert, C. | +14

CommentIn: Eur Respir J. 2023 Mar 23;61(3):. - PMID 36958746

13

Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'

enthalten in: Annals of the rheumatic diseases | 2022

von Jeny, F. | Lhote, R. | Lorillon, G. | +26

CommentOn: Ann Rheum Dis. 2021 Jun;80(6):e87. - PMID 32606044

14

Molecular Alterations in Malignant Pleural Mesothelioma : A Hope for Effective Treatment by Targeting YAP

enthalten in: Targeted oncology | 2022

von Dubois, F. | Bazille, C. | Levallet, J. | +6

15

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

enthalten in: Targeted oncology | 2022

von Dubois, F. | Bazille, C. | Levallet, J. | +6

16

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

enthalten in: Targeted oncology | 2022

von Dubois, F. | Bazille, C. | Levallet, J. | +6

17

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP

enthalten in: Targeted oncology | 2022

von Dubois, F. | Bazille, C. | Levallet, J. | +6

18

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial

enthalten in: International journal of cancer | 2022

von Maille, E. | Levallet, J. | Dubois, F. | +17

19

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Naccache, J. | Jouneau, S. | Didier, M. | +49

CommentIn: Lancet Respir Med. 2022 Jan;10(1):e3. - PMID 34973212

20

Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort

enthalten in: Advances in therapy | 2022

von Cottin, V. | Guéguen, S. | Nunes, H. | +35